Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options
Top Cited Papers
Open Access
- 6 April 2005
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 26 (3), 380-392
- https://doi.org/10.1210/er.2004-0028
Abstract
Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme. The reduction of glucose by the AR-catalyzed polyol pathway has been linked to the development of secondary diabetic complications. Although treatment with AR inhibitors has been shown to prevent tissue injury in animal models of diabetes, the clinical efficacy of these drugs remains to be established. Recent studies suggest that glucose may be an incidental substrate of AR, which appears to be more adept in catalyzing the reduction of a wide range of aldehydes generated from lipid peroxidation. Moreover, inhibition of the enzyme has been shown to increase inflammation-induced vascular oxidative stress and prevent myocardial protection associated with the late phase of ischemic preconditioning. On the basis of these studies, several investigators have ascribed an important antioxidant role to the enzyme. Additionally, ongoing work indicates that AR is a critical component of intracellular signaling, and inhibition of the enzyme prevents high glucose-, cytokine-, or growth factor-induced activation of protein kinase C and nuclear factor-κ-binding protein. Thus, treatment with AR inhibitors prevents vascular smooth muscle cell growth and endothelial cell apoptosis in culture and inflammation and restenosis in vivo. Additional studies indicate that the antioxidant and signaling roles of AR are interlinked and that AR regulates protein kinase C and nuclear factor-κB via redox-sensitive mechanisms. These data underscore the need for reevaluating anti-AR interventions for the treatment of diabetic complications. Potentially, the development of newer drugs that selectively inhibit ARmediated glucose metabolism and signaling, without affecting aldehyde detoxification, may be useful in preventing inflammation associated with the development of diabetic complications, particularly micro- and macrovascular diseases.Keywords
This publication has 100 references indexed in Scilit:
- Inhibitors of Protein Kinase C (PKC) Prevent Activated TranscriptionPublished by Elsevier BV ,2004
- Role of aldose reductase in TNF-α-induced apoptosis of vascular endothelial cellsChemico-Biological Interactions, 2003
- Metabolic regulation of aldose reductase activity by nitric oxide donorsChemico-Biological Interactions, 2001
- Involvement of aldose reductase in the metabolism of atherogenic aldehydesChemico-Biological Interactions, 2001
- Regulation of vascular smooth muscle cell growth by aldose reductaseChemico-Biological Interactions, 2001
- Characterization of the glutathione binding site of aldose reductaseChemico-Biological Interactions, 2001
- Occurrence of Glutathione-Modified Aldose Reductase in Oxidatively Stressed Bovine LensBiochemical and Biophysical Research Communications, 1995
- Aldose reductase mRNA expression and its activity are induced by glucose in fetal rat aortic smooth muscle (A10) cellsLife Sciences, 1992
- Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesisBiochemical and Biophysical Research Communications, 1990
- In vitro modification of bovine lens aldose reductase activityBiochemical and Biophysical Research Communications, 1987